UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206

Journal of cell science, 2015-10, Vol.128 (19), p.3631-3645

2015

Volltextzugriff (PDF)

Gain of RNA function in pathological cases: Focus on myotonic dystrophy

Biochimie, 2011-11, Vol.93 (11), p.2006-2012

2011

Volltextzugriff (PDF)

Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy

Current gene therapy, 2015-01, Vol.15 (4), p.329

2015

Volltextzugriff (PDF)

Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1

Neuropathology and applied neurobiology, 2009-11, Vol.35 (6), p.603-613

2009

Volltextzugriff (PDF)

IGF-1 induces human myotube hypertrophy by increasing cell recruitment

Experimental cell research, 2004-09, Vol.299 (1), p.148-158

2004

Volltextzugriff (PDF)

Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry

Neuromuscular disorders : NMD, 2016-10, Vol.26, p.S194-S194

2016

Volltextzugriff (PDF)

L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains

Science & sports, 2005-08, Vol.20 (4), p.199-201

2005

Volltextzugriff (PDF)

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

Gene therapy, 2003-05, Vol.10 (9), p.795-802

2003

Volltextzugriff (PDF)

O.6 Antisense approach for myotonic dystrophy

Neuromuscular disorders : NMD, 2011-10, Vol.21 (9), p.681-681

2011

Volltextzugriff (PDF)

Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice

Molecular therapy, 2019-08, Vol.27 (8), p.1372-1388

2019

Volltextzugriff (PDF)

P390 PGN-EDODM1 nonclinical data demonstrate mechanistic and meaningful activity for potential treatment of myotonic dystrophy type 1 (DM1)

Neuromuscular disorders : NMD, 2023-10, Vol.33, p.S156-S156

2023

Volltextzugriff (PDF)

P22 High content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC independent pathway in myotonic dystrophy cell lines

Neuromuscular disorders : NMD, 2014-03, Vol.24, p.S12-S12

2014

Volltextzugriff (PDF)

FP.44 Exploring the role of MuscleBlind-Like proteins in the regulation of CaVB1 isoform expression in adult skeletal muscle

Neuromuscular disorders : NMD, 2022-10, Vol.32, p.S129

2022

Volltextzugriff (PDF)

P74 Observations on oligo-based therapy for Myotonic Dystrophy

Neuromuscular disorders : NMD, 2012-03, Vol.22, p.S27-S27

2012

Volltextzugriff (PDF)

P81 Compound screening in myotonic dystrophy

Neuromuscular disorders : NMD, 2012-03, Vol.22, p.S29-S29

2012

Volltextzugriff (PDF)

Defective satellite cells in congenital myotonic dystrophy

Human molecular genetics, 2001-09, Vol.10 (19), p.2079-2087

2001

Volltextzugriff (PDF)

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (33), p.13915-13920

2009

Volltextzugriff (PDF)

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

The Journal of clinical investigation, 2004-07, Vol.114 (2), p.182-195

2004

Volltextzugriff (PDF)

G.P.14.10 Inhibition of prostaglandin E2 (PGE2) production restores the differentiation of congenital human dystrophy myotonic type 1 (CDM1) myoblasts

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.857-857

2007

Volltextzugriff (PDF)

Myoblast transfer therapy: is there any light at the end of the tunnel?

Acta myologica, 2005-10, Vol.24 (2), p.128

2005

Volltextzugriff (PDF)

D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts

Neuromuscular disorders : NMD, 2008-10, Vol.18 (9), p.798-798

2008

Volltextzugriff (PDF)

D.P.4.09 Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles

Neuromuscular disorders : NMD, 2008-10, Vol.18 (9), p.798-799

2008

Volltextzugriff (PDF)

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain

Neuroscience, 1996-11, Vol.75 (1), p.231-243

1996

Volltextzugriff (PDF)

G.P.12.01 Immunodetection of myotubularin in human tissues: A diagnostic tool for X-linked myotubular myopathy

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.635-635

2009

Volltextzugriff (PDF)

Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation

Human gene therapy, 2003-08, Vol.14 (12), p.1169-1179

2003

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(70)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(24)
Humans
(23)
Neurology
(20)
Animals
(14)
Biological And Medical Sciences
(12)
Mice
(12)
Cells, Cultured
(11)
Life Sciences
(11)
Myotonic Dystrophy - Genetics
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Myotonic Dystrophy
(9)
Myotonic Dystrophy - Pathology
(8)
Biochemistry & Molecular Biology
(7)
Genetics & Heredity
(7)
Muscle, Skeletal - Metabolism
(7)
Neurosciences
(7)
Gene Expression
(6)
Medical Sciences
(6)
Medicine, Research & Experimental
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206

Gain of RNA function in pathological cases: Focus on myotonic dystrophy

Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy

Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1

IGF-1 induces human myotube hypertrophy by increasing cell recruitment

Correlation between mutation size and cardiac involvement in myotonic dystrophy type 1: An analysis of the DM1-heart registry

L'IGF-1 induit une augmentation de la taille et du contenu en myosine des myotubes humains

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

O.6 Antisense approach for myotonic dystrophy

Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice

P390 PGN-EDODM1 nonclinical data demonstrate mechanistic and meaningful activity for potential treatment of myotonic dystrophy type 1 (DM1)

P22 High content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC independent pathway in myotonic dystrophy cell lines

FP.44 Exploring the role of MuscleBlind-Like proteins in the regulation of CaVB1 isoform expression in adult skeletal muscle

P74 Observations on oligo-based therapy for Myotonic Dystrophy

P81 Compound screening in myotonic dystrophy

Defective satellite cells in congenital myotonic dystrophy

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

G.P.14.10 Inhibition of prostaglandin E2 (PGE2) production restores the differentiation of congenital human dystrophy myotonic type 1 (CDM1) myoblasts

Myoblast transfer therapy: is there any light at the end of the tunnel?

D.P.4.08 P16 triggers premature senescence of congenital DM1 myoblasts

D.P.4.09 Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain

G.P.12.01 Immunodetection of myotubularin in human tissues: A diagnostic tool for X-linked myotubular myopathy

Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation

Suchergebnisse filtern